ISTA PHARMACEUTICALS INC Financing Cash Flow
ISTA PHARMACEUTICALS INC reported Financing Cash Flow of -$8.39 million for the 3-month period ending 2012-03-31, per its 10-Q filed 2012-05-04.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2012-05-04
- ISTA PHARMACEUTICALS INC net cash provided by (used in) financing activities for the quarter ending 2012-03-31 was -$8.39M, a 1936.54% decline year-over-year.
- ISTA PHARMACEUTICALS INC net cash provided by (used in) financing activities for the quarter ending 2011-12-31 was $193.00K, a 37.94% decline year-over-year.
- ISTA PHARMACEUTICALS INC net cash provided by (used in) financing activities for the quarter ending 2011-09-30 was -$10.42M, a 13462.82% decline year-over-year.
- ISTA PHARMACEUTICALS INC net cash provided by (used in) financing activities for the quarter ending 2011-06-30 was $8.33M.
- ISTA PHARMACEUTICALS INC net cash provided by (used in) financing activities for fiscal 2011 was -$1.45M, a 510.51% decline from fiscal 2010.
- ISTA PHARMACEUTICALS INC net cash provided by (used in) financing activities for fiscal 2010 was $352.00K.
- ISTA PHARMACEUTICALS INC net cash provided by (used in) financing activities for fiscal 2009 was -$2.00M.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2012-03-31 | -$8.39M 10-Q · filed 2012-05-04 | -$8.20M derived: sum of 2 quarters · filed 2012-05-04 | -$18.62M derived: sum of 3 quarters · filed 2012-05-04 | -$10.29M derived: sum of 4 quarters · filed 2012-05-04 |
| 2011-12-31 | $193.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | -$10.23M derived: sum of 2 quarters · filed 2012-02-27 | -$1.90M derived: sum of 3 quarters · filed 2012-02-27 | -$1.45M 10-K · filed 2012-02-27 |
| 2011-09-30 | -$10.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-07 | -$2.10M derived: sum of 2 quarters · filed 2011-11-07 | -$1.64M 10-Q · filed 2011-11-07 | -$1.33M derived: sum of 4 quarters · filed 2012-05-04 |
| 2011-06-30 | $8.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-01 | $8.79M 10-Q · filed 2011-08-01 | $9.10M derived: sum of 3 quarters · filed 2012-05-04 | $9.17M derived: sum of 4 quarters · filed 2012-05-04 |
| 2011-03-31 | $457.00K 10-Q · filed 2012-05-04 | $768.00K derived: sum of 2 quarters · filed 2012-05-04 | $846.00K derived: sum of 3 quarters · filed 2012-05-04 | |
| 2010-12-31 | $311.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | $389.00K derived: sum of 2 quarters · filed 2012-02-27 | $352.00K 10-K · filed 2012-02-27 | |
| 2010-09-30 | $78.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-07 | $41.00K 10-Q · filed 2011-11-07 | ||
| 2010-06-30 | -$37.00K 10-Q · filed 2011-08-01 | |||
| 2009-12-31 | -$2.00M 10-K · filed 2012-02-27 |